PubMed

Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease.

Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M.

Ann Intern Med. 2001 May 1;134(9 Pt 1):746-53.PMID: 11329232 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients.

Comenzo RL, Vosburgh E, Simms RW, Bergethon P, Sarnacki D, Finn K, Dubrey S, Faller DV, Wright DG, Falk RH, Skinner M.

Blood. 1996 Oct 1;88(7):2801-6.PMID: 8839879 [PubMed - indexed for MEDLINE]Related articlesFree article

Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.

Leung N, Dispenzieri A, Fervenza FC, Lacy MQ, Villicana R, Cavalcante JL, Gertz MA.

Am J Kidney Dis. 2005 Aug;46(2):270-7. Review.PMID: 16112045 [PubMed - indexed for MEDLINE]Related articles

High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease.

Casserly LF, Fadia A, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM.

Kidney Int. 2003 Mar;63(3):1051-7.PMID: 12631087 [PubMed - indexed for MEDLINE]Related articles

An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.

Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M.

Bone Marrow Transplant. 2001 Oct;28(7):637-42. Review.PMID: 11704785 [PubMed - indexed for MEDLINE]Related articlesFree article

High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.

Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG.

Ann Intern Med. 2004 Jan 20;140(2):85-93.PMID: 14734330 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.

Comenzo RL, Vosburgh E, Falk RH, Sanchorawala V, Reisinger J, Dubrey S, Dember LM, Berk JL, Akpek G, LaValley M, O'hara C, Arkin CF, Wright DG, Skinner M.

Blood. 1998 May 15;91(10):3662-70.PMID: 9573002 [PubMed - indexed for MEDLINE]Related articlesFree article

Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.

Worel N, Schulenburg A, Mitterbauer M, Keil F, Rabitsch W, Kalhs P, Gisslinger H, Raderer M, Geissler K, Höcker P, Zielinski CC, Oberbauer R, Greinix HT.

Wien Klin Wochenschr. 2006 Feb;118(1-2):49-53.PMID: 16489526 [PubMed - indexed for MEDLINE]Related articles

No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement.

Zeier M, Perz J, Linke RP, Donini U, Waldherr R, Andrassy K, Ho AD, Goldschmidt H.

Nephrol Dial Transplant. 2003 Dec;18(12):2644-7.PMID: 14605290 [PubMed - indexed for MEDLINE]Related articlesFree article

Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.

Leung N, Dispenzieri A, Lacy MQ, Kumar SK, Hayman SR, Fervenza FC, Cha SS, Gertz MA.

Clin J Am Soc Nephrol. 2007 May;2(3):440-4. Epub 2007 Apr 4.PMID: 17699449 [PubMed - indexed for MEDLINE]Related articlesFree article

Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support.

Sezer O, Schmid P, Shweigert M, Heider U, Eucker J, Harder H, Sinha P, Radtke H, Possinger K.

Bone Marrow Transplant. 1999 May;23(9):967-9.PMID: 10338056 [PubMed - indexed for MEDLINE]Related articlesFree article

[High-dose melphalan treatment followed by hematopoietic progenitor cell rescue in primary amyloidosis]

Rives S, Bladé J, Martínez C, Marín P, Carreras E, Montserrat E.

Med Clin (Barc). 2000 Jul 8;115(6):216-20. Spanish. Erratum in: Med Clin (Barc) 2000 Oct 21;115(13):486. PMID: 11002461 [PubMed - indexed for MEDLINE]Related articles

[White blood cell lysis syndrome after autologous peripheral blood stem cell transplantation in the treatment of renal AL amyloidosis. Case report]

Gatica A, Bertin P, Tagle R.

Rev Med Chil. 2006 Jun;134(6):763-6. Epub 2006 Aug 14. Spanish. PMID: 17130952 [PubMed - indexed for MEDLINE]Related articlesFree article

Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation.

Leung N, Slezak JM, Bergstralh EJ, Dispenzieri A, Lacy MQ, Wolf RC, Gertz MA.

Am J Kidney Dis. 2005 Jan;45(1):102-11.PMID: 15696449 [PubMed - indexed for MEDLINE]Related articles

High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study.

Vesole DH, Pérez WS, Akasheh M, Boudreau C, Reece DE, Bredeson CN; Plasma Cell Disorders Working Committee of the Center for International Blood and Marrow Transplant Research.

Mayo Clin Proc. 2006 Jul;81(7):880-8.PMID: 16835967 [PubMed - indexed for MEDLINE]Related articlesFree article

Successful treatment of nephrotic syndrome due to systemic AL amyloidosis after autologous stem cell transplantation: renal response is an important therapeutic end point.

Akay OM, Sahin G, Kabukcuoglu S, Yalcin AU, Gulbas Z.

Clin Nephrol. 2008 Apr;69(4):294-7.PMID: 18397705 [PubMed - indexed for MEDLINE]Related articles

Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients.

Mignot A, Varnous S, Redonnet M, Jaccard A, Epailly E, Vermes E, Boissonnat P, Gandjbakhch I, Herpin D, Touchard G, Bridoux F.

Arch Cardiovasc Dis. 2008 Sep;101(9):523-32. Epub 2008 Nov 17.PMID: 19041836 [PubMed - indexed for MEDLINE]Related articles

Nephrotic syndrome due to primary AL amyloidosis, successfully treated with VAD and subsequent high-dose melphalan followed by autologous peripheral blood stem cell transplantation.

Gono T, Matsuda M, Dohi N, Hoshi K, Tada T, Sakashita K, Koike K, Aizawa M, Ikeda S.

Intern Med. 2003 Jan;42(1):72-7.PMID: 12583623 [PubMed - indexed for MEDLINE]Related articlesFree article

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial.

Sanchorawala V, Wright DG, Seldin DC, Falk RH, Finn KT, Dember LM, Berk JL, Quillen K, Anderson JJ, Comenzo RL, Skinner M.

Bone Marrow Transplant. 2004 Feb;33(4):381-8.PMID: 14676787 [PubMed - indexed for MEDLINE]Related articles

Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis.

Fadia A, Casserly LF, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM.

Kidney Int. 2003 May;63(5):1868-73.PMID: 12675865 [PubMed - indexed for MEDLINE]Related articles